Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Gyeonggi-do, Korea.
J Dig Dis. 2013 Dec;14(12):647-53. doi: 10.1111/1751-2980.12099.
We aimed to validate a new scoring system for the differential diagnosis of gastric subepithelial tumors (SET) based on endoscopic ultrasonography (EUS) findings, and to determine its diagnostic yield for different gastric SET.
Data of patients with gastric SET treated with endoscopic mucosal resection, endoscopic submucosal dissection or surgical resection from April 2001 to October 2012 at the Soonchunhyang University Hospital (Bucheon, Korea) were retrospectively reviewed. Four variables, including location, shape, layer of origin and echogenicity of the tumor on EUS were used to validate the new scoring system.
Among the 226 patients with gastric SET, 69 (30.5%) had gastrointestinal stromal tumors (GIST), 68 (30.1%) had ectopic pancreas and 35 (15.5%) had leiomyoma. Most GIST were located at the fundus and body (79.7%), whereas most leiomyomas were found at the cardia (80.0%). Ectopic pancreas was mostly found at the antrum (88.2%). GIST were mainly irregular and round in shape, while ectopic pancreas and lipoma were oval and leiomyomas were irregularly shaped on EUS. With a score range of 0-1 for leiomyoma, 2-3 for GIST, 4-6 for ectopic pancreas and 7-8 for lipoma, the sensitivity and specificity of the scoring system were 75.8% and 85.4% for GIST, 84.6% and 73.1% for ectopic pancreas, 75.9% and 99.5% for leiomyoma and 91.7% and 96.7% for lipoma, respectively.
The new scoring system was simple and relatively useful for predicting the histology of gastric SET without acquiring tissues. Prospective studies with large sample sizes are needed in the future.
我们旨在验证一种基于内镜超声(EUS)检查结果的胃黏膜下肿瘤(SET)鉴别诊断新评分系统,并确定其对不同胃 SET 的诊断效果。
回顾性分析 2001 年 4 月至 2012 年 10 月在韩国顺天乡大学医院(Bucheon)接受内镜黏膜切除术、内镜黏膜下剥离术或手术切除治疗的胃 SET 患者的数据。使用 EUS 上肿瘤的位置、形状、起源层和回声四个变量来验证新的评分系统。
在 226 例胃 SET 患者中,69 例(30.5%)为胃肠道间质瘤(GIST),68 例(30.1%)为异位胰腺,35 例(15.5%)为平滑肌瘤。大多数 GIST 位于胃底和胃体(79.7%),而大多数平滑肌瘤位于贲门(80.0%)。异位胰腺主要位于胃窦(88.2%)。GIST 在 EUS 上主要呈不规则圆形,而异位胰腺和脂肪瘤呈椭圆形,平滑肌瘤呈不规则形。平滑肌瘤的评分范围为 0-1,GIST 为 2-3,异位胰腺为 4-6,脂肪瘤为 7-8,该评分系统对 GIST 的敏感性和特异性分别为 75.8%和 85.4%,对异位胰腺的敏感性和特异性分别为 84.6%和 73.1%,对平滑肌瘤的敏感性和特异性分别为 75.9%和 99.5%,对脂肪瘤的敏感性和特异性分别为 91.7%和 96.7%。
该新评分系统简单且相对有用,无需获取组织即可预测胃 SET 的组织学特征。未来需要进行更大样本量的前瞻性研究。